330
Participants
Start Date
February 25, 2025
Primary Completion Date
February 28, 2029
Study Completion Date
September 30, 2029
Ambroxol Hydrochloride (420mg)
Oral tablet
Placebo
Oral tablet
NOT_YET_RECRUITING
University Hospitals Birmingham, Birmingham
NOT_YET_RECRUITING
Southmead Hospital Bristol, Bristol
NOT_YET_RECRUITING
Addenbrookes NHS Trust, Cambridge
NOT_YET_RECRUITING
Western General Hospital, Edinburgh
NOT_YET_RECRUITING
Kings College London, London
NOT_YET_RECRUITING
Royal London Hospital, London
RECRUITING
University College London Hospital's, London
NOT_YET_RECRUITING
Newcastle, Newcastle
NOT_YET_RECRUITING
Northumbria, Newcastle upon Tyne
NOT_YET_RECRUITING
The John Radcliffe Hospital, Oxford
RECRUITING
Derriford Hospital, Plymouth
NOT_YET_RECRUITING
Fairfield General Hospital, Salford
RECRUITING
Salford Royal Hospital, Salford
NOT_YET_RECRUITING
Southampton General Hospital, Southampton
NOT_YET_RECRUITING
Prince Philip Hospital, Wales
University College, London
OTHER